Hourly refreshWed, Oct 28, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

3,485 press releases in English indexed under healthcare.

Clear all filters
Keywords, dates and language
Sources
up to 10
Newswires (50)
Company newsrooms (91)
Companies
Releases linked to any of up to 10 companies
AllFinanceCryptoAISaaSHealthcareReal estateEnergyRetailAutomotiveGamingMediaEducation
+ 33 more topics
DownloadExcelTXT
AI · Healthcare

Endoscopes Market Size to Reach USD 41.09 Billion by 2035 as Disposable and AI-Assisted Systems Gain Ground – SNS Insider

U.S. Endoscopes Market projected at USD 12.09 billion by 2035 on rising hospital procedures; Europe reaches USD 8.33 billion, supported by established health coverage and device manufacturing. U.S. Endoscopes Market projected at USD 12.09 billion by 2035 on rising hospital procedures; Europe reaches USD 8.33 billion, supported by established health coverage and device manufacturing.

Aug 24 · 15:00GlobeNewswire
Healthcare · Biotech & pharma

Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)

Company announcement No. 41 / 2026

Aug 24 · 15:00GlobeNewswire
Healthcare

Imricor Supports HRS Call for Enhanced Radiation Protection and Urges a Future Beyond Radiation Exposure

MINNEAPOLIS, August 24, 2026--Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), the pioneer in the interventional magnetic resonance (iMR) field, welcomed the Heart Rhythm Society’s call for the urgent and immediate adoption of enhanced radiation-protection measures for clinicians and staff working in fluoroscopy-based procedure environments.1

Aug 24 · 14:10Business Wire
Finance · Healthcare

Kaplan Fox Reminds Hims & Hers Health, Inc. (HIMS) Investors of an Investigation into Potential Securities Law Violations

New York, New York--(August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATIONIf you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing...

Aug 24 · 14:00Newsfile
Healthcare · Biotech & pharma

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions

Executive Chairman and Former FDA Associate Commissioner Peter J. Pitts to deliver keynote presentations on establishing an FDA Abraham Accords Office and restructuring NIH research grant models. Pitts to moderate expert sessions on Translational Pharmaceutical Innovation and the Emerging...

Aug 24 · 12:15PR Newswire
Healthcare

The Vitamin Shoppe Promotes Jack Gayton to Senior Vice President, Merchandising

Merchandising leader to advance The Vitamin Shoppe's growth strategy through product innovation, differentiated assortments, and strategic brand partnerships SECAUCUS, N.J., Aug. 24, 2026 -- The Vitamin Shoppe®, a leading specialty retailer of health and wellness products,...

Aug 24 · 12:05PR Newswire
Healthcare · Real estate

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

U.S. publication of the patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration with Neurothera Labs Inc. as the FDA  introduces a dedicated regulatory structure for psychedelic drug development, including MDMA

Aug 24 · 12:03GlobeNewswire
Healthcare · Automotive

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Aug 24 · 12:00GlobeNewswire
Healthcare · Food & drink

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

– Supplemental Biologics License Application (BLA) expected to be filed with the Food and Drug Administration (FDA) in November 2026 –

Aug 24 · 12:00GlobeNewswire
Finance · Healthcare

Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

BOSTON, Aug. 24, 2026 -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that management will participate in one-on-one meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston, MA.

Aug 24 · 12:00GlobeNewswire
Healthcare

74% of Healthcare Organizations Rate Their Patient Data Quality as Mixed or Poor, New Clinical Architecture Report Finds

CARMEL, Ind., August 24, 2026--New report reveals a growing healthcare data trust gap, with poor-quality patient data creating challenges for interoperability and care.

Aug 24 · 12:00Business Wire
Healthcare · Biotech & pharma

QurAlis to Participate in Upcoming Investor Conferences in September

CAMBRIDGE, Mass., August 24, 2026--QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of neurodegenerative and neurological diseases, today announced that Kasper Roet, Ph.D., CEO and co-founder, will participate at the following investor conferences in September. Management will also participate in one-on-one investor meetings.

Aug 24 · 11:45Business Wire